Q4 2024 Holdings
Filed 2025-02-14 | 73 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $31.1M | 475,000 | 1.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $31.6M | 3,350,000 | 1.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $31.8M | 810,000 | 1.9% |
| Savara Inc(SVRA) | COM | 805111101 | $33.1M | 10,775,000 | 2.0% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $33.8M | 1,000,000 | 2.0% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $36.2M | 750,000 | 2.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $36.4M | 475,000 | 2.2% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $37.4M | 4,180,000 | 2.2% |
| Geron Corp(GERN) | COM | 374163103 | $38.9M | 11,000,000 | 2.3% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $40.4M | 4,770,000 | 2.4% |
| Immatics NV(IMTX) | SHS | N44445109 | $44.6M | 6,275,000 | 2.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $45.5M | 1,075,000 | 2.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $46.8M | 1,725,000 | 2.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $47.0M | 600,000 | 2.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $47.6M | 1,060,000 | 2.8% |
| uniQure NV(QURE) | SHS | N90064101 | $53.4M | 3,025,000 | 3.2% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $56.5M | 860,000 | 3.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $62.1M | 900,000 | 3.7% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $63.1M | 1,500,000 | 3.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $71.6M | 520,000 | 4.2% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $79.6M | 800,000 | 4.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $110.5M | 2,350,000 | 6.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $120.1M | 975,000 | 7.1% |